Sign in
Already have access? Choose your edition
Sign-in is edition-specific. New here? Start with the free brief instead of jumping straight into a trial.
Each edition has its own app, pricing, and coverage page. Use sign-in if you already have access; otherwise pick an edition and get the free daily + weekly brief first.
AI
Daily briefings on AI labs, policy, tooling, and community shifts.
Best for
- Model releases + evals
- Policy and safety narratives
- Tooling and platform shifts
Featured signalUnlocked today
Anthropic has introduced Claude Design, a new AI-powered product that enables users to generate designs, prototypes, presentation slides, and marketing mater...
Crypto
Daily briefings on markets, protocols, narratives, and risk events.
Best for
- Market structure + regulation
- Security and exploit narratives
- Protocol + dev ecosystem
Featured signalUnlocked today
Payward, the parent company of Kraken, has agreed to acquire Bitnomial, a U.S.-based crypto derivatives exchange fully licensed by the Commodity Futures Trad...
CYBERSECURITY
Daily briefings on vulnerabilities, incidents, and threat intel.
Best for
- Vulns and advisories
- Incidents + exploit narratives
- Vendor and community disclosures
Featured signalUnlocked today
Authorities from over 20 countries collaborated in Operation PowerOFF, targeting and dismantling numerous DDoS-for-hire platforms.
ENERGY
Daily briefings on the energy transition: policy, grid, storage, and markets.
Best for
- Grid + reliability narratives
- Policy + first-party data
- Storage + transition supply chain
Featured signalUnlocked today
Coverage discusses speculative scenarios around ~£600M; treat as market chatter and see linked sources.
BIOTECH
Daily briefings on clinical, regulatory, and R&D updates from public sources.
Best for
- Clinical + regulatory narratives
- Research + preprints
- Funding + market updates
Featured signalUnlocked today
Recent preclinical studies introduce novel methods and mechanisms that deepen understanding of immune checkpoint inhibitor (ICI) therapy outcomes.